Participant safety
Protecting human participants is a top priority. Timely detection and management of adverse reactions or side effects ensure participant safety.
Are you exploring options to outsource pharmacovigilance safety management for your upcoming clinical trial involving medicinal products for human use? Ensuring comprehensive safety oversight is not just essential—it’s critical to the success of your trial.
At QbD Group, we offer full pharmacovigilance services for the safety management of your clinical trials.
Pharmacovigilance is the science of detecting, assessing, and preventing adverse effects or drug-related problems during clinical trials. High-quality safety data is essential to:
To meet global and local regulatory requirements (e.g., Regulation EU No 536/2014 or Directive 2001/20/EC), guidelines (e.g., ICH-E6, ICH-E2B, ICH-E2F etc.), clinical trials require precise, traceable, and compliant safety management.
Protecting human participants is a top priority. Timely detection and management of adverse reactions or side effects ensure participant safety.
Compliance with ALCOA(+) principles ensures data quality, enabling smooth trial progression and eventual marketing authorization.
Strict safety monitoring compliance avoids delays and regulatory issues, keeping your trial on track.
Do you lack an in-house safety team, or just need expert guidance in safety management? QbD Group is here to help.
Expertise you can trust
With a team of highly skilled professionals boasting extensive experience, we ensure the utmost quality and safety for our clients.
24/7 accessibility
We ensure that our clients receive prompt assistance and support whenever they require it.